Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients

BACKGROUND AND AIM: Non‐alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in different countries. Liver fibrosis is considered as the most appropriate predictor of NAFLD‐associated outcome. Microfibrillar‐associated protein 4 (MFAP4) is a glycoprotein located in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanaan, Reine, Yaghi, Cesar, Saade Riachy, Carole, Schlosser, Anders, Hamade, Aline, Holmskov, Uffe, Medlej‐Hashim, Myrna, Sørensen, Grith Lykke, Jounblat, Rania
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037036/
https://www.ncbi.nlm.nih.gov/pubmed/36968563
http://dx.doi.org/10.1002/jgh3.12873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037036/
https://www.ncbi.nlm.nih.gov/pubmed/36968563
http://dx.doi.org/10.1002/jgh3.12873

Ejemplares similares